Content about Specialty Pharmacy

March 30, 2010
Sanofi-Aventis, AgaMatrix announce diabetes partnership

French drug maker Sanofi-Aventis and U.S.-based AgaMatrix will develop blood-glucose monitoring devices that use an...

March 29, 2010
CVS Caremark receives URAC accreditation

CVS Caremark announced on Tuesday that it has been awarded specialty pharmacy accreditation from URAC,...

March 29, 2010
Pliva Hrvastka gets tentative approval for argatroban

The Food and Drug Administration has given a tentative approval to a generic drug for...

March 28, 2010
FDA approves Zyclara

The Food and Drug Administration has approved a new drug made by Graceway Pharmaceuticals for...

March 28, 2010
Tianyin names new CFO, chief development officer

A company in China that manufactures modernized traditional Chinese medicine has appointed a new executive...

March 25, 2010
FDA committee to review Qnexa

A Food and Drug Administration committee will review a drug by Vivus for obesity, the...

March 25, 2010
New clinical trial will compare MS drugs

Swiss drug maker Biogen Idec and Irish drug maker Elan Corp. have started enrolling patients...

March 24, 2010
BioScrip completes Critical Homecare Solutions acquisition

BioScrip has created one of the largest home care providers in the United States with...

March 24, 2010
FDA approves expanded use of Xifaxan

The Food and Drug Administration has approved a new use for a drug made by...

March 23, 2010
Diamyd Medical receives orphan drug designation

The Food and Drug Administration has given orphan drug designation to a vaccine for Type...

March 23, 2010
FDA to have Genzyme plant inspected, reviewed

Genzyme Corp. will have to submit to inspections of one of its plants by the...

March 23, 2010
SVP product development and clinical operations

A company that develops drugs for inflammatory diseases has made a new executive appointment....

March 22, 2010
Boehringer Ingelheim receives FDA approval for expanded use of Mirapex ER

Less than a month after winning approval for treating early stages of Parkinson’s disease, a...

March 22, 2010
FDA committee won't recommend approval for non-Hodgkin’s lymphoma treatment

A Food and Drug Administration advisory committee declined to recommend approval for a cancer drug...

March 22, 2010
Merck KGaA suspends cancer vaccine trial

A mid-stage clinical trial program to investigate a Merck KGaA cancer vaccine has been put...

March 21, 2010
Decision Resources projects more than 150% growth in multiple myeloma market

The market for drugs that treat a cancer of the bone marrow will more than...

March 21, 2010
Shingles drug may capture half the market, Decision Resources predicts

A once-a-day formulation of a Pfizer drug potentially could capture half of the market for...

March 18, 2010
Citing potential problems, FDA declines to approve A.P. Pharma drug

The Food and Drug Administration raised a number of concerns that it said precluded the...

March 18, 2010
High doses of cholesterol drug may raise muscle injury risk, FDA warns

Patients taking a common drug for treating high cholesterol may be at increased risk of...

March 18, 2010
NHVR: Increased funding needed for viral hepatitis screening, intervention

“Systemic underfunding” at the Centers for Disease Control and Prevention’s Division of Viral Hepatitis puts...

WASHINGTON “Systemic underfunding” at the Centers for Disease Control and Prevention’s Division of Viral Hepatitis puts the health of millions of Americans with viral hepatitis at risk, a group of organizations focused on the disease said this week.

March 17, 2010
FDA approves Carbaglu

The Food and Drug Administration has approved a drug for treating a condition that causes...

March 17, 2010
Merck, Portola release results of mid-stage betrixaban trial

An investigational pill reduced bleeding in patients with atrial fibrillation better than a widely available...

March 17, 2010
Pfizer presents efficacy data of Prevenar 13 at conference

A phase-3 clinical trial found that a pneumococcal disease vaccine was well-tolerated and immunogenic in...

March 17, 2010
Roche calls its R&D status 'uniquely positioned'

Roche leaders appear confident about their company’s research and development position, with several investigational drugs...

March 16, 2010
MiddleBrook expanding promotion of Moxatag through IncreaseRx program

MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the...

WESTLAKE, Texas MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the drug maker announced Wednesday.

IncreaseRx is a virtual sales-contract organization that gives healthcare professionals access to electronic sampling, learning and education tools. The company has entered an agreement with DoctorDirectory.com, its promotion partner for Moxatag (amoxicillin), and plans to use Web-based educational and promotional tactics to reach prescribers with sales and marketing messages for the drug.